Trans-Cardiac Gradient of Secretoneurin in Patients with Takotsubo Syndrome
Cardiology · 2024
DOI: 10.1159/000539094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, 2024. Verfasst von Helge Røsjø und 6 weiteren Autor:innen. Beteiligte Einrichtung: Akershus Clinical Research Center (ACR), Division of Research and Innovation, Akershus University Hospital, Lørenskog, Norway. Hauptthemen laut MEDLINE: Takotsubo Cardiomyopathy, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Introduction
Secretoneurin (SN) is a novel biomarker that provides prognostic information in patients with cardiovascular disease. In experimental models, SN production is increased in the failing myocardium. Currently, no information is available on SN production in human myocardium. Accordingly, we wanted to determine the trans-cardiac gradient of SN in patients with Takotsubo syndrome (TTS), and to correlate circulating SN concentrations with indices of cardiac structure and function.
Methods
We included 15 women diagnosed with TTS according to established criteria. Plasma SN concentrations were measured in blood samples obtained simultaneously from the aortic root and the coronary sinus. Coronary physiology was assessed by invasive measurements, and we used cardiac magnetic resonance imaging to determine left ventricular ejection fraction (LVEF) and cardiac mass.
Results
Median age was 65 years and median LVEF was 45%. Median SN concentration was 39 (25th–75th percentile 31–44) pmol/L in the coronary sinus and 37 (30–41) pmol/L in the aortic root (p = 0.02 for difference). SN concentrations in the aortic root showed the highest correlations with N-terminal B-type natriuretic peptide (rho = 0.47) and estimated glomerular filtration rate (rho = −0.41). In contrast, we found weak correlations between SN concentrations and index of myocardial resistance (rho = 0.12), LVEF (rho = 0.08), and cardiac mass (rho = −0.09).
Conclusion
We demonstrate a positive trans-cardiac gradient of SN in patients with TTS, which supports the hypothesis that SN is produced and released in the human myocardium in situations of myocardial dysfunction and stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Akershus Clinical Research Center (ACR), Division of Research and Innovation, Akershus University Hospital, Lørenskog, Norway.
- K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
- Division of Radiology and Nuclear Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
- Division of Medicine, Department of Cardiology, Akershus University Hospital, Lørenskog, Norway.
- Division of Medicine, Department of Pulmonary Medicine, Akershus University Hospital, Lørenskog, Norway.
Zitieren
APA
Røsjø, H., Solberg, O. G., Aaberge, L., Bosse, G., Omland, T., Stavem, K., & Myhre, P. L. (2024). Trans-Cardiac Gradient of Secretoneurin in Patients with Takotsubo Syndrome. Cardiology. https://doi.org/10.1159/000539094
Vancouver
Røsjø H, Solberg OG, Aaberge L, Bosse G, Omland T, Stavem K, et al. Trans-Cardiac Gradient of Secretoneurin in Patients with Takotsubo Syndrome. Cardiology. 2024. doi:10.1159/000539094
BibTeX
@article{Rsj2024,
author = {Røsjø, Helge and Solberg, Ole Geir and Aaberge, Lars and Bosse, Gerhard and Omland, Torbjørn and Stavem, Knut and Myhre, Peder L},
title = {Trans-Cardiac Gradient of Secretoneurin in Patients with Takotsubo Syndrome},
journal = {Cardiology},
year = {2024},
doi = {10.1159/000539094}
}
EUVIMED